Company Filing History:
Years Active: 2019-2025
Title: **Simone Del Favero: Innovating Continuous Glucose Monitoring**
Introduction
Simone Del Favero is an accomplished inventor based in Valle di Cadore, Italy, recognized for her significant contributions to the field of continuous glucose monitoring. With a total of three patents, her innovative work focuses on enhancing the accuracy and precision of glucose concentration profiles, crucial for the effective management of diabetes.
Latest Patents
One of Simone's most notable patents is a "Retrospective retrofitting method to generate a continuous glucose concentration profile by exploiting continuous glucose monitoring sensor data and blood glucose measurements." This invention addresses the limitations of Continuous Glucose Monitoring (CGM) devices, which often provide glucose concentration readings with limited accuracy. The proposed 'retrofitting' algorithm improves the generation of a quasi-continuous blood glucose profile by integrating high-accuracy reference measurements with the high-temporal-resolution data from CGM devices. This innovative approach allows for better outcome metrics in clinical trials, reducing the need for frequent blood glucose reference measurements and thereby minimizing the burden on patients.
Career Highlights
Simone currently works at Dexcom, Inc., a company renowned for its advancements in CGM technology. Her role involves not just research and development but also the practical application of her inventions to improve patient care. The innovative methodologies she has developed are expected to transform how glycemic-regulation therapies are evaluated in clinical settings.
Collaborations
Simone collaborates with notable professionals in her field, including Claudio Cobelli and Andrea Facchinetti. Their combined expertise fosters a robust environment for pioneering research and development in glucose monitoring technology, pushing the boundaries of what's possible in patient health management.
Conclusion
Simone Del Favero exemplifies the spirit of innovation in the field of continuous glucose monitoring. Her work not only advances technology but also significantly impacts patient outcomes. As the landscape of diabetes management continues to evolve, her contributions remain vital in making meaningful strides toward enhanced healthcare solutions.